HEALY JAMES
Related Filers (64)
- POWELL MICHAEL (57)
- Natera, Inc. (29)
- Buatois Eric (28)
- Mehra Anand (26)
- Sofinnova Management VII, L.L.C. (21)
- SOFINNOVA VENTURE PARTNERS VII L P (21)
- INTERMUNE INC (21)
- Coherus BioSciences, Inc. (20)
- Azan Alain (18)
- AMARIN CORP PLC\UK (18)
- Karuna Therapeutics, Inc. (17)
- Sofinnova Management VIII, L.L.C. (13)
- Sofinnova Venture Partners VIII, L.P. (13)
- SOFINNOVA VENTURE PRINCIPALS V LP (12)
- SOFINNOVA VENTURE PARTNERS V LP (12)
- Sofinnova Management V LLC (12)
- SOFINNOVA VENTURE AFFILIATES V LP (12)
- Sofinnova Venture Partners IX, L.P. (12)
- Sofinnova Management IX, L.L.C. (12)
- Anthera Pharmaceuticals Inc (11)
- AKKARAJU SRINIVAS (11)
- Sofinnova Management X, L.P. (11)
- Sofinnova Venture Partners X, L.P. (11)
- Y-mAbs Therapeutics, Inc. (9)
- Sofinnova Management VI, L.L.C. (8)
- SOFINNOVA VENTURE PARTNERS VI L P (8)
- Sofinnova Venture Partners VI GmbH & Co. KG (8)
- Sofinnova Venture Affiliates VI LP (8)
- COTHERIX INC (7)
- HYPERION THERAPEUTICS INC (7)
- Iterum Therapeutics plc (7)
- Katabi Maha (6)
- NOVACEA INC (5)
- AERIE PHARMACEUTICALS INC (5)
- Edge Therapeutics, Inc. (5)
- CinCor Pharma, Inc. (5)
- Bolt Biotherapeutics, Inc. (5)
- KALOBIOS PHARMACEUTICALS INC (4)
- Vera Therapeutics, Inc. (4)
- Sofinnova Management V 2005, LLC (3)
- Trius Therapeutics Inc (3)
- Ocera Therapeutics, Inc. (3)
- MARINUS PHARMACEUTICALS INC (3)
- NextCure, Inc. (3)
- THRESHOLD PHARMACEUTICALS INC (2)
- ANESIVA, INC. (2)
- Durata Therapeutics, Inc. (2)
- Versartis, Inc. (2)
- ALIMERA SCIENCES INC (2)
- HISTOGENICS CORP (2)
- aTYR PHARMA INC (2)
- Mirna Therapeutics, Inc. (2)
- Aclaris Therapeutics, Inc. (2)
- Principia Biopharma Inc. (2)
- Entasis Therapeutics Holdings Inc. (2)
- Galera Therapeutics, Inc. (2)
- Akouos, Inc. (2)
- Inozyme Pharma, Inc. (2)
- Checkmate Pharmaceuticals, Inc. (2)
- Aerovate Therapeutics, Inc. (2)
- Sofinnova Management X-A, L.L.C. (2)
- ArriVent Biopharma, Inc. (2)
- Kong Garheng (1)
- Spark Therapeutics, Inc. (1)
- Show More ...
Ownership (224)
4
Wednesday, 1/31/2024
ArriVent Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/30/2024
Natera, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/25/2024
ArriVent Biopharma, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 12/22/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/31/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/1/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2023
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/14/2023
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/18/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
CinCor Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/8/2023
Vera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/18/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/18/2023
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/18/2022
Natera, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 9/2/2022
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/15/2022
CinCor Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/8/2022
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/8/2022
CinCor Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/19/2022
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/12/2022
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/14/2022
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/28/2022
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
Vera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 2/11/2022
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
CinCor Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/10/2022
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/6/2022
CinCor Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/29/2021
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/26/2021
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/7/2021
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/6/2021
Aerovate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/29/2021
Aerovate Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Vera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/13/2021
Vera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/4/2021
Bolt Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/13/2021
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/1/2020
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/11/2020
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/9/2020
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/1/2020
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/12/2020
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/6/2020
Checkmate Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/28/2020
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/1/2020
Akouos, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/25/2020
Akouos, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/24/2020
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/3/2020
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/23/2020
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Friday, 1/17/2020
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/14/2020
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/14/2020
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/13/2020
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/27/2019
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/25/2019
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/19/2019
NextCure, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/12/2019
Galera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/6/2019
Galera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 11/1/2019
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/1/2019
Karuna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/27/2019
Karuna Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/24/2019
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/17/2019
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Friday, 6/14/2019
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/24/2019
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/15/2019
NextCure, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
NextCure, Inc.: Initial statement of beneficial ownership of securities
4/A
Tuesday, 4/16/2019
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/16/2019
Natera, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/30/2019
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/2/2018
Entasis Therapeutics Holdings Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/25/2018
Entasis Therapeutics Holdings Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/25/2018
Y-mAbs Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/20/2018
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/20/2018
Y-mAbs Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/18/2018
Natera, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/13/2018
Principia Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Friday, 8/31/2018
Coherus BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/30/2018
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/29/2018
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities